Hydrogel Foams could be a key component in delivering medication lasting up to six months for many different chronic diseases. The foams are able to protect the proteins without altering their original state, allowing them to last longer. Researchers at the University of Cambridge in the U.K. are working toward this with biodegradable polymer sponges that can release drugs over long periods to treat diabetes, cancer and other chronic diseases such as HIV/AIDS,or act as templates for tissue regeneration after surgery or injury. The rate of release can be controlled by simply altering the formula.
One of the biggest demographics to benefit from this kind of treatment would be patients who aren’t able to access medical facilities regularly. The longevity of the medication will also help minimize the treatments of patients with chronic diseases, and ultimately increase patient compliance. Can this form of drug delivery eventually help to slow down the progression of a disease?
At Drug Delivery Partnerships, hundreds of pharmaceutical and drug delivery thought leaders come together to develop partnerships to create the next great product that will bring relief to millions of patients. Sign up for updates on the 17th Annual Drug Delivery Partnerships Conference taking place February 6-8, 2012, in San Diego, CA.